Document is current
Any future updates will be listed below
-
Authors
Koenig, Alena
Porzelt, Sarah
Behrens-Potratz, Anja
Stratmeyer, Peter
Schellhammer, Stefanie
Schmage, Petra
Konnopka, Claudia
Scherer, Martin
Konnopka, Alexander
Zimmermann, Thomas
-
Funding
Funding for this research was provided by:
Hochschule für Angewandte Wissenschaften Hamburg (HAW Hamburg)
- License Information
-
More Information
Article History
Received: 22 December 2023
Accepted: 17 June 2024
First Online: 26 June 2024
Declarations
:
: The Medical Review Board of the Hamburg Medical Chamber approved the InSEMaP study (approval number: 2021-100715-BO-ff). The study was conducted in accordance with the principles of the Declaration of Helsinki. The questionnaires were sent by the statutory health insurance DAK-Gesundheit to the selected group of insured persons who met the inclusion criteria. Completed questionnaires were returned to the study management by the respondents without address or any other personal details in an enclosed, pre-stamped envelope. After consultation with the ethics committee, the return of a completely anonymised questionnaire is considered informed consent.
: The study was prospectively included in the German Clinical Trials Register (DRKS) on 04/01/2022: DRKS00027020. .
: Not applicable.
: The authors declare no competing interests.
